Get to know us. Our independent credit research, global market insights, covenant analysis and news help the world鈥檚 financial decision makers manage risk better.
Bausch Health: Initial Impressions on the Strategic Alternatives Update
Anthony P. Canale, J.D.. - Global Head of Research, Covenant Review
EXECUTIVE SUMMARY
On February 6, Bausch Health Companies, Inc. (the 鈥淐ompany鈥 or 鈥淏HC鈥) issued a press release updating the market on strategic alternatives (the 鈥淪trategic Update鈥). In this Strategic Update, the Company disclosed that the sale process it had engaged in regarding a potential sale of Bausch + Lomb Corporation (鈥淏+L鈥) did not lead to an offer that reflected 叠+尝鈥檚 long–term value, and the BHC and B+L boards determined not to move forward with a sale at this time. The Company also disclosed that it will continue its efforts to work on various liability management alternatives, including raising new debt financing.
In this report, we provide our initial impressions on the Strategic Update and how the provisions of the various Bausch Health bonds could be implicated.
Would you like access to the full report?
Receive a complimentary copy of Bausch Health: Initial Impressions on the Strategic Alternatives Update
Award-Winning, Completely Unbiased Research
On the investment grade and high yield securities of issuers around the globe.
Select an article to download a free piece of research.
Filter

Hertz: Do the Indentures and the Credit Agreement Permit Uptiering the 2026s into Second-Lien Debt?

Asia Credit: 2H26 Outlook and Sector Strategy

3Q 2026 US IG & HY Sector Strategy Overview

US IG/LevFin 2H26/1H27 Outlook: Tightly Wound

Asia Chart of the Day: Australia Trip Note
Our 乱伦短视频
乱伦短视频 combines credit market research, covenant analysis and leveraged finance news into one site to help you Know More. Risk Better.